메뉴 건너뛰기




Volumn 362, Issue 9389, 2003, Pages 1041-1044

Deaths due to absence of an affordable antitoxin for plant poisoning

Author keywords

[No Author keywords available]

Indexed keywords

ANTITOXIN; DIGOXIN ANTIBODY; PLANT TOXIN;

EID: 0141760464     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)14415-7     Document Type: Article
Times cited : (44)

References (8)
  • 1
    • 0032915769 scopus 로고    scopus 로고
    • Epidemic of self-poisoning with seeds of the yellow oleander tree (Thevetia peruviana) in northern Sri Lanka
    • Eddleston M., Ariaratnam C.A., Meyer P.W., et al. Epidemic of self-poisoning with seeds of the yellow oleander tree (Thevetia peruviana) in northern Sri Lanka. Trop Med Int Health. 4:1999;266-273.
    • (1999) Trop Med Int Health , vol.4 , pp. 266-273
    • Eddleston, M.1    Ariaratnam, C.A.2    Meyer, P.W.3
  • 2
    • 0038661052 scopus 로고    scopus 로고
    • Acute plant poisoning and antitoxin antibodies
    • Eddleston M., Persson H. Acute plant poisoning and antitoxin antibodies. J Toxicol Clin Toxicol. 41:2003;309-315.
    • (2003) J Toxicol Clin Toxicol , vol.41 , pp. 309-315
    • Eddleston, M.1    Persson, H.2
  • 3
    • 0034681834 scopus 로고    scopus 로고
    • Anti-digoxin Fab fragments in cardiotoxicity induced by ingestion of yellow oleander: A randomised controlled trial
    • Eddleston M., Rajapakse S., Rajakanthan K., et al. Anti-digoxin Fab fragments in cardiotoxicity induced by ingestion of yellow oleander: a randomised controlled trial. Lancet. 355:2000;967-972.
    • (2000) Lancet , vol.355 , pp. 967-972
    • Eddleston, M.1    Rajapakse, S.2    Rajakanthan, K.3
  • 4
    • 0034021196 scopus 로고    scopus 로고
    • Acute yellow oleander (Thevetia peruviana) poisoning: Cardiac arrhythmias, electrolyte disturbances, and serum cardiac glycoside levels on presentation to hospital
    • Eddleston M., Ariaratnam C.A., Sjostrom L., et al. Acute yellow oleander (Thevetia peruviana) poisoning: cardiac arrhythmias, electrolyte disturbances, and serum cardiac glycoside levels on presentation to hospital. Heart. 83:2000;301-306.
    • (2000) Heart , vol.83 , pp. 301-306
    • Eddleston, M.1    Ariaratnam, C.A.2    Sjostrom, L.3
  • 5
    • 0037097042 scopus 로고    scopus 로고
    • Differential pricing of drugs: A role for cost-effectiveness analysis?
    • Lopert R., Lang D.L., Hill S.R., Henry D.A. Differential pricing of drugs: a role for cost-effectiveness analysis? Lancet. 359:2002;2105-2107.
    • (2002) Lancet , vol.359 , pp. 2105-2107
    • Lopert, R.1    Lang, D.L.2    Hill, S.R.3    Henry, D.A.4
  • 6
    • 0037401660 scopus 로고    scopus 로고
    • Report of a WHO workshop on the standardization and control of antivenoms
    • Theakston R.D.G., Warrell D.A., Griffiths E. Report of a WHO workshop on the standardization and control of antivenoms. Toxicon. 41:2003;541-557.
    • (2003) Toxicon , vol.41 , pp. 541-557
    • Theakston, R.D.G.1    Warrell, D.A.2    Griffiths, E.3
  • 8
    • 0037157590 scopus 로고    scopus 로고
    • Drug development for neglected diseases: A deficient market and a public health policy failure
    • Trouiller P., Olliaro P., Torreele E., Orbinski J., Laing R., Ford N. Drug development for neglected diseases: a deficient market and a public health policy failure. Lancet. 359:2002;2188-2194.
    • (2002) Lancet , vol.359 , pp. 2188-2194
    • Trouiller, P.1    Olliaro, P.2    Torreele, E.3    Orbinski, J.4    Laing, R.5    Ford, N.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.